Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMSCs in Werdnig-Hoffman Disease
NCT02855112Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in spinal muscular atrophy type 1, sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
spinal muscular atrophy type 1
Beyond the preview
Go deeper on NCT02855112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855112.